AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Rapport Therapeutics (RAPP) Plunges 5.07% After Reaching 2025 High
Generated by AI AgentAinvest Movers Radar
Friday, Jul 11, 2025 6:45 pm ET1min read
Rapport Therapeutics (RAPP) shares experienced a significant decline, dropping by 5.07% today. The stock price reached its highest level since February 2025, with an intraday gain of 2.08%.
The strategy of buying shares after they reach a recent high and selling them one week later delivered moderate returns but came with significant volatility and risk. The strategy’s CAGR was 1.94% with an excess return of 102.09% relative to the benchmark, which had a return of -100.00%. However, the strategy had a maximum drawdown of 0.00% and a Sharpe ratio of 0.02, indicating it managed risk well but offered conservative returns.On July 11, 2025, there was no relevant information regarding the causes of changes in
(RAPP) stock price according to the criteria provided.
Ainvest Movers Radar
Knowing stock market today at a glance
Latest Articles
ATRenew (RERE) Climbs 4.02% on Strong Q3 Results, Apple-Huawei Partnerships Boost Revenue 28.7%
Dec.18 2025
Compass (COMP) Rallies 1.99% Amid Antitrust Scrutiny Over $1.5B Acquisition
Dec.18 2025
Suzano (SUZ) Shares Surge 6.79% as 400% Capacity Expansion Targets Sustainable Absorbent Products Demand
Dec.18 2025
Iamgold (IAG) Rallies 2.15% in 3 Days on Share Buyback, Debt Reduction Amid Gold Sector Strength
Dec.18 2025
Village Farms International Stock Dives 6.46% Amid U.S. Cannabis Regulatory Uncertainties and Strategic Risks
Dec.18 2025
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet